Global Information
회사소개 | 문의 | 비교리스트

인도의 체외수정(IVF) 시장 : 예측과 기회(-2025년)

India In-vitro Fertilization Market By Technique, By Equipment, By Fertilization, By Donor, By Infertility, By Embryo, By Application, By End User, By Region, Competition, Forecast & Opportunities, 2025

리서치사 TechSci Research
발행일 2020년 05월 상품 코드 938731
페이지 정보 영문 71 Pages
가격
US $ 2,950 ₩ 3,373,000 Unprintable PDF and Excel (Single User License)
US $ 3,750 ₩ 4,287,000 PDF and Excel (Multi-User License)
US $ 7,500 ₩ 8,575,000 PDF and Excel (Custom Research License)

TechSci Research 보고서는 10% Customization 서비스가 포함되어 있습니다. 보고서에 포함돼 있지 않은 리서치 데이터와 시장 동향을 추가적으로 요청할 수 있습니다. 자세한 사항은 문의하여 주시기 바랍니다.



인도의 체외수정(IVF) 시장 : 예측과 기회(-2025년) India In-vitro Fertilization Market By Technique, By Equipment, By Fertilization, By Donor, By Infertility, By Embryo, By Application, By End User, By Region, Competition, Forecast & Opportunities, 2025
발행일 : 2020년 05월 페이지 정보 : 영문 71 Pages

본 상품은 영문 자료로 한글과 영문목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문목차를 참고해주시기 바랍니다.

인도의 체외수정 시장은 예측기간 중 상당한 속도로 성장할 것으로 예상됩니다. 시장은 국가의 의료 인프라 개선과 적정 가격 최신 의료 시설의 이용 가능성으로 견인될 것으로 기대되고 있습니다.

인도의 체외수정(In-vitro Fertilization) 시장을 부문별 및 지역별로 조사했으며, 시장 규모 및 시장 점유율 예측, 성장 촉진요인과 과제, 시장 동향, 경쟁 상황, 기업 개요 등의 정보를 제공합니다.

목차

제1장 제품 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 소리

제5장 인도의 체외수정 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 기술별(타이밍 지도(IC) 또는 주기 모니터링, 배란 유발(OI), 인공수정(IUI), 도너수정(IUDI), 난모세포제공(DOP), 체외수정, 미세수정, 배아 유리화·동결 배아 이식(FET), 정소 정자 추출(TESE)·경피적 부고환 정자 흡인(PESA))
    • 기기별(IVF 배지, IVF 인큐베이터, 마이크로매니퓰레이터, Cryosystem cabinet, 흡인 펌프, 기타)
    • 수정별(표준 수정, 난세포질내 정자 주입(ICSI), 자궁내 수정)
    • 도너별(자가, 동종, 대리)
    • 불임별(남성, 여성, 남성·여성 양쪽 모두)
    • 배아별(신선 배아, 동결 융해 배아)
    • 용도별(난관 손상 또는 폐색, 배란 장애, 자궁내막증, 자궁근종, 난관 멸균 또는 제거, 정자 생성 또는 기능 장애, 원인불명 불임, 유전성 장애, 암 또는 기타 건강 상태에서의 불임 치료)
    • 최종사용자별(불임 치료 클리닉, 병원, 기타)
    • 지역별
    • 기업별
  • 시장 매력 지수

제6장 북인도의 체외수정 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 기술별
    • 기기별
    • 수정별
    • 도너별
    • 불임별
    • 배아별
    • 용도별
    • 최종사용자별

제7장 남인도의 체외수정 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 기술별
    • 기기별
    • 수정별
    • 도너별
    • 불임별
    • 배아별
    • 용도별
    • 최종사용자별

제8장 동인도의 체외수정 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 기술별
    • 기기별
    • 수정별
    • 도너별
    • 불임별
    • 배아별
    • 용도별
    • 최종사용자별

제9장 서인도의 체외수정 시장 전망

  • 시장 규모와 예측
  • 시장 점유율과 예측
    • 기술별
    • 기기별
    • 수정별
    • 도너별
    • 불임별
    • 배아별
    • 용도별
    • 최종사용자별

제10장 시장 역학

  • 성장 촉진요인/기회
  • 과제/성장 저해요인

제11장 시장 동향과 발전

제12장 정책과 규제 상황

제13장 인도의 경제 개요

제14장 경쟁 상황

  • 기업 개요
    • Lab IVF
    • Lg Life sciences India Pvt. Ltd
    • Merck
    • Cook Medical
    • Cipla
    • Alembic Pharmaceutical
    • Glenmark pharmaceutical
    • Cadila pharmaceutical
    • Cooper Surgical
    • Fujifilm
    • Hamilton Thorne
    • Nikon cooperation
    • Thermo Fisher Scientific Inc.
    • Vitrolife AB
    • Adorefem
    • Sobha Medical Equipment
    • ART Biotech
    • SAR Healthline
    • Surelife

제15장 전략적 추천사항

제16장 면책사항

KSM 20.06.16

India in-vitro fertilization market is expected to grow at a formidable rate during the forecast period. The India in-vitro fertilization market is driven by the improving healthcare infrastructure in the country and availability of modern healthcare facilities at affordable prices. This fact is also giving rise to medical tourism thereby propelling the market in the country. Additionally, changing lifestyle patterns are leading to various diseases such as PCOS and other kinds of reproductive diseases. Furthermore, increasing number of single super specialty hospitals is projected to fuel the market over the next few years.

The India in-vitro fertilization market is segmented based on technique, equipment, fertilization, donor, infertility, embryo, application, end user, region and company. Based on equipment, the market can be fragmented into IVF culture media, IVF incubators, micromanipulator, cryosystem cabinet, aspiration pumps and others. The IVF culture media segment is expected to dominate the market during the forecast period since culture media is required in every IVF procedure. Semen processing media, ovum processing media, cryopreservation media, and embryo culture media are the major culture media types used during IVF procedures. Additionally, major players are launching improved versions of their culture media thereby driving the growth of segment.

Major players operating in the India in-vitro fertilization market include Lab IVF, Lg Life sciences India Pvt. Ltd, Merck, Cook Medical, Cipla, Alembic Pharmaceutical, Glenmark pharmaceutical, Cadila pharmaceutical, Cooper Surgical, Fujifilm, Hamilton Thorne, Nikon cooperation, Thermo Fisher Scientific Inc., Vitrolife AB, Adorefem, Sobha Medical Equipment, ART Biotech, SAR Healthline, Surelife and others.

Years considered for this report:

Historical Years: 2015-2018

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2021-2025

Objective of the Study:

  • To analyze and forecast the market size of India in-vitro fertilization market.
  • To classify and forecast India in-vitro fertilization market based on technique, equipment, fertilization, donor, infertility, embryo, application, end user, company and regional distribution.
  • To identify drivers and challenges for India in-vitro fertilization market.
  • To examine competitive developments such as expansions, new product launches, mergers & acquisitions, etc., in India in-vitro fertilization market.
  • To conduct pricing analysis for India in-vitro fertilization market.
  • To identify and analyze the profile of leading players operating in India in-vitro fertilization market.

TechSci Research performed both primary as well as exhaustive secondary research for this study. Initially, TechSci Research sourced a list of fertility centers across the globe. Subsequently, TechSci Research conducted primary research surveys with the identified companies. While interviewing, the respondents were also enquired about their competitors. Through this technique, TechSci Research could include the manufacturers which could not be identified due to the limitations of secondary research. TechSci Research analyzed the manufacturers, distribution channels and presence of all major players across the globe.

TechSci Research calculated the market size of India in-vitro fertilization market using a bottom-up approach, wherein data for various end-user segments was recorded and forecast for the future years. TechSci Research sourced these values from the industry experts and company representatives and externally validated through analyzing historical data of these product types and applications for getting an appropriate, overall market size. Various secondary sources such as company websites, news articles, press releases, company annual reports, investor presentations and financial reports were also studied by TechSci Research.

Key Target Audience:

  • In-vitro fertilization fertility centers, hospitals/clinics and other stakeholders
  • Government bodies such as regulating authorities and policy makers
  • Organizations, forums and alliances related to in-vitro fertilization
  • Market research and consulting firms

The study is useful in providing answers to several critical questions that are important for the industry stakeholders such as fertility centers, hospitals and clinics, end users, etc., besides allowing them in strategizing investments and capitalizing on market opportunities.

Report Scope:

In this report, India in-vitro fertilization market has been segmented into following categories, in addition to the industry trends which have also been detailed below:

  • Market, By Technique:

Timed Intercourse (IC) or Cycle Monitoring

Ovulation Induction (OI)

Artificial insemination using Partner's semen (IUI)

Donor Insemination (IUDI)

Oocyte Donation (DOP)

In-vitro Fertilization

Intra cytoplasmic sperm injection

Embryo Vitrification & Frozen Embryo Transfer (FET)

Testicular Sperm Extraction (TESE) & Percutaneous Epididymal Sperm Aspiration (PESA)

  • Market, By Equipment:

IVF culture media

IVF incubators

Micromanipulator

Cryosystem cabinet

Aspiration pumps

Others

  • Market, By Fertilization:

Conventional Insemination

Intracytoplasmic sperm injection (ICSI)

Intra-uterine Fertilization

  • Market, By Donor:

Autologous

Allogenic

Surrogacy

  • Market, By Infertility:

Male

Female

Both male and female

  • Market, By Embryo:

Fresh embryo

Frozen-thawed embryo

  • Market, By Application:

Fallopian tube damage or blockage

Ovulation disorders

Endometriosis

Uterine fibroids

Previous tubal sterilization or removal

Impaired sperm production or function

Unexplained infertility

Genetic disorder

Fertility preservation for cancer

Other health conditions

  • Market, By End User:

Fertility clinics

Hospitals

Others

  • Market, By Region:

North

South

East

West

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in India in-vitro fertilization market.

Available Customizations:

With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product of Interest Introduction: In-vitro Fertilization

2. Research Methodology

3. Executive Summary

4. Voice of Customer

5. India In-vitro Fertilization Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Technique (Timed Intercourse (IC) or Cycle Monitoring, Ovulation Induction(OI) , Artificial insemination using Partner's semen(IUI) ,Donor Insemination (IUDI), Oocyte Donation (DOP),In-vitro Fertilization, Intra cytoplasmic sperm injection, Embryo Vitrification & Frozen Embryo Transfer (FET), Testicular Sperm Extraction (TESE) & Percutaneous Epididymal Sperm Aspiration (PESA))
    • 5.2.2. By Equipment (IVF culture media, IVF incubators, Micromanipulator, Cryosystem cabinet, Aspiration pumps and others)
    • 5.2.3. By Fertilization (Conventional Insemination, Intracytoplasmic sperm injection (ICSI), Intra-uterine Fertilization)
    • 5.2.4. By Donor (Autologous, Allogenic, Surrogacy)
    • 5.2.5. By Infertility (Male, Female, Both male and female)
    • 5.2.6. By Embryo (Fresh embryo and Frozen-thawed embryo)
    • 5.2.7. By Application (Fallopian tube damage or blockage, Ovulation disorders, Endometriosis, Uterine fibroids, Previous tubal sterilization or removal, Impaired sperm production or function, Unexplained infertility, Genetic disorder, Fertility preservation for cancer or other health conditions)
    • 5.2.8. By End User (Fertility clinics, Hospitals and others)
    • 5.2.9. By Region (North, South, East, West)
    • 5.2.10. By Company
  • 5.3. Market Attractiveness Index

6. North India In-vitro Fertilization Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Technique
    • 6.2.2. By Equipment
    • 6.2.3. By Fertilization
    • 6.2.4. By Donor
    • 6.2.5. By Infertility
    • 6.2.6. By Embryo
    • 6.2.7. By Application
    • 6.2.8. By End User

7. South India In-vitro Fertilization Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Technique
    • 7.2.2. By Equipment
    • 7.2.3. By Fertilization
    • 7.2.4. By Donor
    • 7.2.5. By Infertility
    • 7.2.6. By Embryo
    • 7.2.7. By Application
    • 7.2.8. By End User

8. East India In-vitro Fertilization Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Technique
    • 8.2.2. By Equipment
    • 8.2.3. By Fertilization
    • 8.2.4. By Donor
    • 8.2.5. By Infertility
    • 8.2.6. By Embryo
    • 8.2.7. By Application
    • 8.2.8. By End User

9. West India In-vitro Fertilization Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Technique
    • 9.2.2. By Equipment
    • 9.2.3. By Fertilization
    • 9.2.4. By Donor
    • 9.2.5. By Infertility
    • 9.2.6. By Embryo
    • 9.2.7. By Application
    • 9.2.8. By End User

10. Market Dynamics

  • 10.1. Drivers/Opportunities
  • 10.2. Challenges/Restraints

11. Market Trends & Developments

12. Policy & Regulatory Landscape

13. India Economic Profile

14. Competitive Landscape

  • 14.1. Company Profiles
    • 14.1.1. Lab IVF
    • 14.1.2. Lg Life sciences India Pvt. Ltd
    • 14.1.3. Merck
    • 14.1.4. Cook Medical
    • 14.1.5. Cipla
    • 14.1.6. Alembic Pharmaceutical
    • 14.1.7. Glenmark pharmaceutical
    • 14.1.8. Cadila pharmaceutical
    • 14.1.9. Cooper Surgical
    • 14.1.10. Fujifilm
    • 14.1.11. Hamilton Thorne
    • 14.1.12. Nikon cooperation
    • 14.1.13. Thermo Fisher Scientific Inc.
    • 14.1.14. Vitrolife AB
    • 14.1.15. Adorefem
    • 14.1.16. Sobha Medical Equipment
    • 14.1.17. ART Biotech
    • 14.1.18. SAR Healthline
    • 14.1.19. Surelife

15. Strategic Recommendations

16. About Us & Disclaimer

Back to Top
전화 문의
F A Q